miércoles, 7 de diciembre de 2022

Universal Health Coverage Day 2022 - Lymphostatic Elephantiasis - Essential Health Care - Pediatric and Primary Lymphedema – Secondary Lymphedema - Filariasis/Podoconiosis - Lipedema - Chronic Venous Insufficiency - Awareness Campaign

International health organizations and national health systems should list lymphatic dysfunction, lipedema, and venous insufficiency management as essential, as part of the campaign for universal health coverage around the world. Essential health care for adults and Children should be supplied at the national and local levels. Nontreatment or undertreatment of these diseases leads to disease progression regarding disability, disfigurement, and major complications. Inappropriate treatments also promote and prolong patient suffering at physical and psychological levels and loss of quality of life.

With reference to the treatment of lymphedema, regardless of the cause or setting, it should be the number one goal of countries in all regions of the world. But the reality right now is that millions of people are still undertreated or have no access at all to health care. Millions more are forced to choose between health care and food, clothing, or even a home. Elephantiasis is preventable in the majority of cases, if the underlying cause which is lymphoedema, is treated in its initial mild stages. In the case of lymphatic filariasis (LF), it is recognized that in many cases it is first acquired in childhood, often as many as one-third of children are infected before age 5.

Scientific studies highlight the importance and implications of compression therapy in controlling the progression of lymphatic dysfunction, lipedema, and venous insufficiency. Clinical outcomes on interventions to manage lymphedema, show that simple hygiene-based measures are necessary, but these alone are not enough to reduce the limb size and volume. Limb and genital Lymphedema should always be treated in their early stages, and not left undertreated till reaching its late severe stage “elephantiasis”. 

Together we must celebrate this day, a day to push toward universal health coverage for people who suffer disabling diseases, such as “Lymphatic Dysfunction”, “Lipedema” or “Chronic Venous Insufficiency”. People should be taught to recognize symptoms and know when to see a physician for diagnosis, and national health systems should give access to correct treatment for these diseases.



Lymphedema is a serious chronic and progressive disease due to an organic disability. The clinical treatment of lymphedema is neither a cosmetic nor an aesthetic treatment. The treatment of lymphedema is to control its progression and alleviate the symptoms related to dysfunction of the lymphatic circulatory system. To prevent and avoid serious complications associated with treatment, such as the possible displacement of edema to previously unaffected areas when compression therapy is applied for volume reduction, patients should use highly specialized and experienced therapists. 

Professional qualification and instruction delivered remotely online are not the same as live hands-on practical instruction in the clinical training and certification of lymphedema therapists, similar to all other rehabilitation, medical, and surgical training programs, and especially for developing the necessary manual skills to treat a disease as complex as lymphedema. 

Patients should also take special care when choosing a "Multidisciplinary Center of Reference for Lymphedema", as not all countries and centers provide the same treatment options. The best choice is a center of reference that provides “Complete Decongestive Therapy (CDT)”, which is recognized as the “Gold Standard” treatment for lymphedema.

  • Read more about what is the best treatment option for Lymphedema HERE.
  • Read about what are the principal functions of Manual Lymphatic Drainage HERE.
  • Read about what are the main differences between the two principal lymphedema treatment protocols HERE. 
  • Read about what are the strategies for the implementation of low-cost treatment options for Lymphedema HERE.


(Click on the texts to read the research articles)











Print this post